Apolipoprotein E alleles as risk factors in Alzheimer's disease

Annual Review of Medicine

Volumn 47, Issue , 1996, Pages 387-400

  Roses, Allen D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aging; Etiology; Genetic; Linkage; MAP2; Pathogenesis; Tau

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; MICROTUBULE ASSOCIATED PROTEIN 2; TAU PROTEIN;

ALZHEIMER DISEASE; GENE LOCUS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; ONSET AGE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BRAIN; CHROMOSOME MAPPING; FEMALE; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; RISK FACTORS;

EID: 0030005627     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.47.1.387     Document Type: Review

References (66)

1. Pericak-Vance MA, Bebaut JL, Gaskell PJ, et al. 1991. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am. J. Hum. Genet. 48:1034-50
2. Strittmatter WJ, Saunders AM, Schmechel D, et al. 1993. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90:1977-81
3. Saunders AM, Strittmatter WJ, Schmechel D, et al. 1993. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-72
4. Lander ES, Schork NJ. 1994. Genetic dissection of complex traits. Science 265: 2037-48
5. Goate A, Chartier HM, Mullan M, et al. 1991. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349: 704-6
6. Sherrington R, Rogaev EI, Liang Y, et al. 1995. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375:754-60
7. Rogaev E, Sherrington R, Rogaeva E, et al. 1995. Familial Alzheimer's disease in kindreds with missense mutations in a novel gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. In press
8. Levy-Lahad E, Wijsman EM, Nemens E, et al. 1995. A familial Alzheimer's disease locus on chromosome 1. Science 269: 970-73
9. Levy-Lehad E, Wasco W, Poorkaj P, et al. 1995. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269:973-77
10. Wecks DE, Lange K. 1988. The affected-pedigree-member method of linkage analysis. Am. J. Hum. Genet. 42:315-26
11. Weisgraber KH. 1994. Apolipoprotein E: structure-function relationships. Adv. Protein Chem. 45:249-302
12. Strittmatter WJ, Weisgraber KH, Huang DY, et al. 1993. Binding of human apolipoprotein E to synthetic amyloid betapeptide: isoform-specific effects and implications for late-onsel Alzheimer disease. Proc. Natl. Acad. Sci. USA 90:8098-102
13. Schachter F, Faure DL, Guenot F, et al. 1994. Genetic associations with human longevity at the APOE and ACE loci. Nat. Genet. 6:29-32
14. McKhann G, Drachman D, Folstein M, et al. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939-44
15. Mirra SS, Heyman A, McKeel D, et al. 1991. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuro pathologic assessment of Alzheimer's disease. Neurology 41:479-86
16. Khachaturian ZS. 1985. Diagnosis of Alz heimer's disease. Arch. Neurol. 42: 1097-105
17. Saunders AM, Schmader K, Breitner JC, et al. 1993. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 342:710-11
18. Amouyel P, Brousseau T, Fruchart JC, Dallongeville J. 1993. Apolipoprotein E-sigma-4 allele and Alzheimer's disease. Lancet 342:1309
19. Borgaonkar DS, Schmidt LC, Martin SE, et al. 1993. Linkage of late-onset Alzheimer's disease with apolipoprotein E type 4 on chromosome 19. Lancet 342:625
20. Houlden H, Crook R, Duff K, et al. 1993. Confirmation that the apolipoprotein E4 allele is associated with late onset, familial Alzheimer's disease. Neurodegeneration 2: 283-86
21. Lucotte G, David F, Visvikis S, et al. 1993. Apolipoprotein E-epsilon 4 allele and Alzheimer's disease. Lancet 342:1309
22. Noguchi S, Murakami K, Yamada N. 1993. Apolipoprotein E genotype and Alzheimer's disease. Lancet 342:737
23. Poirier J, Davignon J, Bouthillier D, et al. 1993. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342:697-99
24. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. 1993. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11: 575-80
25. Ueki A, Kawano M, Namba Y, et al. 1993. A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci. Lett. 163:166-68
26. Lannfelt L, Lilius L, Nastase M, et al. 1994. Lack of association between apolipoprotein E allele epsilon 4 and sporadic Alzheimer's disease. Neurosci. Lett. 169: 175-78
27. Basun H, Grut M, Winblad B, Lannfelt L. 1995. Apolipoprotein epsilon 4 allele and disease progression in patients with late-onset Alzheimer's disease. Neurosci. Lett. 183:32-34
28. Dai XY, Nanko S, Hattori M, et al. 1994. Association of apolipoprotein E4 with sporadic Alzheimer's disease is more pronounced in early onset type. Neurosci. Lett. 175:74-76
29. Kawamata J, Tanaka S, Shimohama S, et al. 1994. Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. J. Neurol. Neurosurg. Psychiatry 57:1414-16
30. Mayeux R, Stern Y, Ottman R, et al. 1993. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann. Neurol. 34:752-54
31. Maestre G, Ottman R, Stern Y, et al. 1995. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann. Neurol. 37:254-59
32. Hendrie HC, Hall KS, Hui S, et al. 1995. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann. Neurol. 37: 118-20
33. Kuusisto J, Koivisto K, Kervinen K, et al. 1994. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. Br. Med. J. 309:636-38
34. Corder EH, Saunders AM, Strittmatter WJ, et al. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-23
35. Corder EH, Saunders AM, Risen NJ, et al. 1994. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet. 7:180-84
36. Roses AD. 1994. Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J. Neuropathol. Exp. Neurol. 53:429-37
37. Roses AD, Strittmatter WJ, Pericak VM, et al. 1994. Clinical application of apolippprotein E genotyping to Alzheimer's disease. Lancet 343:1564-65
38. van Duijn CM, de Knijff P, Cruts M, et al. 1994. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat. Genet. 7:74-78
39. Okuizumi K, Onodera O, Tanaka H, et al. 1994. ApoE-epsilon4 and early-onset Alzheimer's (letter). Nat. Genet. 7:10-11
40. Sakoda S, Kuriyama M, Osame M, et al. 1994. Apolipoprotein E epsilon 4. Neurology 44:2420
41. Alzheimer's Disease Collaborative Group. 1993. Apolipoprotein E genotype and Alzheimer's disease. Lancet 342:737-38
42. Nacmias B, Latorraca S, Piersanti P, et al. 1995. ApoE genotype and familial Alzheimer's disease: a possible influence on age of onset in APP717 Val→Ile mutated families. Neurosci. Lett. 183:1-3
43. St. George-Hyslop P, McLachlan DC, Tsuda T, et al. 1994. Alzheimer's disease and possible gene interaction. Science 263: 537
44. Rogaev E, Sherrington R, Rogaeva E, et al. 1995. Familial Alzheimer's disease in kindreds with missense mutations in a novel gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376: 600-2
45. Small GW, Mazziotta JC, Collins MT, et al. 1995. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer's disease. JAMA 273:942-47
46. Petersen RC, Smith GE, Ivnik RJ, et al. 1995. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 273:1274-78
47. Jobst KA, Smith AD, Szatmari M, et al. 1992. Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet 340: 1179-83
48. Jobst KA, Smith AD, Szatmari M, et al. 1994. Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease. Lancet 343:829-30
49. Nicoll JAR, Roberts GW, Graham DI. 1995. Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injury. Nat. Med. 1:135-37
50. Newman MR, Croughwell ND, Blumenthal JA, et al. 1995. Predictors of cognitive decline after cardiac operation. Ann. Thorac. Surg. 59:1326-30
51. Alberts MJ, Graffagnino C, McClenny C, et al. 1995. ApoE genotype and survival from intracerebral hemorrhage. Lancet 346:575
52. Roses AD, Saunders AM. 1995. Head injury, amyloid β and Alzheimer's disease. Nat. Med. 1:603-4
53. Ohm TG, Kirca M, Bohl J, et al. 1995. Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience 66:583-87
54. Roses AD. 1995. Apolipoprotein E genotyping in differential diagnosis, not prediction, of Alzheimer's disease. Ann. Neurol. 38:6-14
55. Poirier J, Delisle M-C, Quirion R, et al. 1995. Apolipoprotein E4, cholinergic integrity, synaptic plasticity and Alzheimer's disease. In Apolipoprotein E and Alzheimer's Disease, ed. A Roses, K Weisgraber. Y Christen. Berlin: Springer-Verlag. In press
56. Anouyel P, Neuman E, Dilleman L, et al. 1995. Characterization of the apolipoprotein E genotypes in clinical trials of Alzheimer's disease: the S12024 (memory enhancer) European multicentre project. In Apolipoprotein E and Alzheimer 's disease, ed. A Roses, K Weisgraber, Y Christen. Berlin: Springer. In press
57. Namba Y, Tomonaga M, Kawasaki H, et al. 1991. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541:163-66
58. Schmechel DE, Saunders AM, Strittmatter WJ, et al. 1993. Increased amyloid betapeptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90:9649-53
59. Han SH, Hulette C, Saunders AM, et al. 1994. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls. Exp. Neurol. 128:13-26
60. Han SH, Einstein G, Weisgraber KH, et al. 1994. Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study. J. Neuropathol. Exp. Neurol. 53:535-44
61. Polvikoski T, Sulkava R, Haltia M, et al. 1995. Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein. N. Engl. J. Med. 333:1242-47
62. Corder EH, Saunders AM, Strittmatter WJ, et al. 1995. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology 45:1323-28
63. Braak H, Braak E. 1992. The human entorhinal cortex: normal morphology and lamina-specific pathology in varous diseases. Neurosci. Res. 15:6-31
64. Strittmatter WJ, Saunders AM, Goedert M, et al. 1994. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc. Natl. Acad. Sci. USA 91:11183-86
65. Huang DY, Goedert M, Jakes R, et al. 1994. Isoform-specific interactions of apolipoprotein E with the microtubule associated protein MAP2c: implications for Alzheimer's disease. Neurosci. Lett. 182:55-58
66. Strittmatter WJ, Weisgraber KH, Goedert M, et al. 1994. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp. Neurol. 125:163-71